Debra Panke, DO
Child & Adolescent Psychiatry · Mansfield, OHNPI 1548393531
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Supernus Pharmaceuticals, Inc. accounts for 70.0% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $6,858 and has fallen 87.1% since, to $882 in 2025. Among child & adolescent psychiatry clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 193 payments — averaging $51.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$7K
- Corium, LLC$493
- Alkermes, Inc.$416
- Otsuka America Pharmaceutical, Inc.$387
- Lundbeck LLC$375
- E.r. Squibb & Sons, L.L.C.$240
- plus $1K from 13 others
What the payments were for
- Speaking & faculty fees$4,62547%
- Travel & lodging$1,44115%
- Food & beverage$3,80038%
- Education$611%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 50 | $6,951 |
| Corium, LLC | 31 | $493 |
| Alkermes, Inc. | 23 | $416 |
| Otsuka America Pharmaceutical, Inc. | 15 | $387 |
| Lundbeck LLC | 19 | $375 |
| E.r. Squibb & Sons, L.L.C. | 5 | $240 |
| Ironshore Pharmaceuticals Inc. | 11 | $225 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $223 |
| Johnson & Johnson | 7 | $125 |
| Idorsia Pharmaceuticals US Inc | 1 | $94 |
| Axsome Therapeutics, Inc. | 4 | $90 |
| Vanda Pharmaceuticals Inc. | 3 | $76 |
| AbbVie(2 entities) | 4 | $60 |
| Teva Pharmaceuticals USA, Inc. | 2 | $50 |
| Tris Pharma Inc | 2 | $41 |
| Shire North American Group Inc | 2 | $26 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,927 in reported general payments places this provider in the 90th percentile of 160 child & adolescent psychiatry providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate ErQuetiapine Fumarate | 55 | $6,948 |
| Methylphenidate ErMethylphenidate Hcl | 19 | $2,283 |
| Clonidine Hcl ErClonidine Hcl | 11 | $918 |
| Haloperidol | 26 | $799 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $322 |
| Lactulose | 13 | $229 |
| Benztropine Mesylate | 17 | $109 |
| Trazodone Hcl | 11 | $62 |
| Citalopram HbrCitalopram Hydrobromide | 13 | $32 |
| Fluoxetine Hcl | 17 | $19 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Mansfield
- Jamila KhanMansfield$665
- Rick BowersMoraine$182K
- Robert FindlingCleveland$125K
- Joseph RiemanFremont$56K
- Melissa DelbelloCincinnati$36K
- Andre ProchoroffCleveland$26K
- Peter GoldenAkron$21K
- Daniel WeisMiddletown$13K
- John VraciuCanton$11K
- Barbara GraciousColumbus$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.